Enyedy Mark J has filed 6 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 1438 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ($CRL) on May 08, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Enyedy Mark J | Director | A | Common Stock | 1438 | $177.62 | 2,384.0000 | 49,217,000 | 152.01% | 0.00% |
| June 2, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Enyedy Mark J | Director | A | Common Stock | 946 | $135.04 | 946.0000 | 51,201,000 | 9999.99% | 0.00% |
| June 2, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Enyedy Mark J | Director | A | Stock Options (Right to Buy) | 2082 | $135.04 | 2,082.0000 | 51,201,000 | 9999.99% | 0.00% |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Enyedy Mark J | Director | A | Common Stock | 6650 | $0.00 | 13,550.0000 | 196,708,000 | 96.38% | 0.00% |
| May 21, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Enyedy Mark J | Director | A | Common Stock | 4720 | $0.00 | 6,900.0000 | 191,595,000 | 216.51% | 0.00% |
| Dec. 27, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Enyedy Mark J | Director | A | Common Stock | 2180 | $0.00 | 2,180.0000 | 188,963,000 | 9999.99% | 0.00% |